Avoro Life Sciences Offshore Fund Ltd. — Form D/A

Avoro Life Sciences Offshore Fund Ltd. of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2025-05-02. $2.1B was reported sold. Industry: Pooled Investment Fund.

Offering

Issuer

Officers, directors & promoters (19)

NameRoleLocation
Behzad AghazadehExecutive OfficerNew York, NY
Neil CammarosanoExecutive OfficerNew York, NY
Scott EpsteinExecutive OfficerNew York, NY
- Avoro Capital Advisors LLCPromoterNew York, NY
- Avoro Capital GP, LLCPromoterNew York, NY
- Avoro Capital L.P.PromoterNew York, NY
Kurt von EmsterDirectorRedwood City, CA
Kurt von EmsterExecutive OfficerRedwood City, CA
Behzad AghazadehRelated PersonNew York, NY
Scott EpsteinRelated PersonNew York, NY
Neil CammarosanoRelated PersonNew York, NY
Corey GoodmanExecutive OfficerCambridge, MA
Robert AdelmanExecutive OfficerSan Francisco, CA
N/A venBio Select Advisor LLCPromoterNew York, NY
N/A venBio Select Advisor Management Holdings GP, LLCPromoterNew York, NY
N/A venBio Select Advisor L.P.PromoterNew York, NY
LLC venBio Select AdvisorPromoterSan Francisco, CA
Paul BrookeDirectorSan Francisco, CA
Paul BrookeExecutive OfficerSan Francisco, CA

Other filings by this issuer (16)

Showing 15 of 16 filings.

FiledFormOfferingSold
2026-05-01D/A$2.2B
2024-05-02D/A$2.0B
2023-05-02D/A$1.8B
2022-05-02D/A$1.4B
2021-05-03D/A$1.1B
2020-05-06D/A$927.3M
2019-05-22D/A$674.9M
2018-09-07D/A$642.8M
2017-10-11D/A$361.0M
2016-10-11D/A$249.3M
2015-10-09D/A$178.5M
2014-10-17D/A$65.8M
2013-10-21D/A$21.9M
2012-11-08D/A$16.4M
2011-08-01D/A$14.4M

More